Clinical Trials Sponsored by Samsung Medison

Total 4302 results

Samsung Medical Center

Recruiting

Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis

Cardiac Amyloidosis

Korea, Republic of
Samsung Medical Center

Recruiting

Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

Unresectable Localized Soft Tissue Sarcoma

Korea, Republic of
Samsung Medical Center

Recruiting

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Pediatric Cancer Patients

Korea, Republic of
Samsung Medical Center

Recruiting

Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.

Metastatic Cancer

Korea, Republic of
Samsung Medical Center

Recruiting

Prospective Registration of Head and Neck Cancer

Head and Neck Cancer

Korea, Republic of
Samsung Medical Center

Recruiting

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Peripheral T-cell Lymphoma

Korea, Republic of
Samsung Medical Center

Recruiting

Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer

Sarcoma

Korea, Republic of
Samsung Medical Center

Active, not recruiting

The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer

Lung Neoplasms

Korea, Republic of
Samsung Medical Center

Completed

Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease

Parkinson Disease
Samsung Medical Center

Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold (SMART-CHOICEII)

Coronary Artery Disease | Atherosclerosis | Stents

Korea, Republic of
Samsung Medical Center

Completed

Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes

Coronary Artery Disease | Cancer
Samsung Medical Center

Active, not recruiting

Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive

Gastric Cancer

Korea, Republic of
Samsung Medical Center

Completed

Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient

Stroke | Rehabilitation | Cognitive Function

Korea, Republic of
Samsung Medical Center

Active, not recruiting

COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

Prostate Neoplasm

Korea, Republic of
Samsung Medical Center

Completed

Proton Beam Therapy for Unresectable Liver Metastasis

Side Effect | Local Control Rate

Korea, Republic of
Samsung Medical Center

Completed

Effects of Constraint-induced Movement Therapy With Home-based Hand-arm Bimanual Intensive Therapy in Children With Unilateral Cerebral Palsy

Cerebral Palsy, Spastic Hemiplegic

Korea, Republic of
Samsung Medical Center

Completed

Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of
Samsung Medical Center

Terminated

The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance

Hepatocellular Carcinoma | Insulin Resistance

Korea, Republic of
Samsung Medical Center

Completed

Application of Transcranial Direct Current Stimulation (tDCS) for Gait Function Improvement of Parkinson's Disease Patient

Parkinson Disease

Korea, Republic of
Samsung Medical Center

Completed

Data Collection for Motor Function and Gait Pattern Analysis of Patients With Chronic Stroke

Chronic Stroke

Korea, Republic of
Samsung Medical Center

Completed

The Effect of Exercise With Wearable Walking Assist Robot in Various Environments

Aging

Korea, Republic of
Samsung Medical Center

Completed

Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

Korea, Republic of
Samsung Medical Center

Enrolling by invitation

Body Composition Analysis and Time to Emergence From Remimazolam

Body Composition | Remimazolam

Korea, Republic of
Samsung Medical Center

Enrolling by invitation

Utilizing of Augmented Reality Technology Education Program for Nurse.

Education | Nursing

Korea, Republic of
Samsung Medical Center

Withdrawn

Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)

Gastric Cancer

Korea, Republic of
Samsung Medical Center

Completed

The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

Interstitial Cystitis

Korea, Republic of
Samsung Medical Center

Completed

Use of Perfusion Index Change as a Predictor of Hypotension During Propofol Sedation in Adult Patients Undergoing Hip Surgery Under Spinal Anesthesia: A Prospective Observational Study

Hypotension | Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Korea, Republic of
Samsung Medical Center

Completed

Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

Genitourinary Cancer | Metastatic Gastrointestinal Cancer

Korea, Republic of
Samsung Medical Center

Completed

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Refractory Solid Tumors

Korea, Republic of
Samsung Medical Center

Withdrawn

A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea

Intrahepatic Cholangiocarcinoma
Samsung Medical Center

Completed

Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

Advanced Gastric Adenocarcinoma

Korea, Republic of
Samsung Medical Center

Active, not recruiting

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

Gastric Adenocarcinoma | Malignant Melanoma

Korea, Republic of
Samsung Medical Center

Completed

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Solid Tumor

Korea, Republic of
Samsung Medical Center

Withdrawn

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Biliary Tract Cancer

Korea, Republic of
Samsung Medical Center

Active, not recruiting

Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study

Colorectal Cancer

Korea, Republic of
Samsung Medical Center

Completed

Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

Advanced Gastric Adenocarcinoma

Korea, Republic of
Samsung Medical Center

Completed

Evaluation of Social Robot Usability for Pediatric Patients and Carers

Pediatrics

Korea, Republic of
Samsung Medical Center

Active, not recruiting

A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder

Urinary Bladder

Korea, Republic of
Samsung Medical Center

Completed

Effects of Comprehensive Augmented and Virtual Reality in Stroke Patients

Stroke

Korea, Republic of
Samsung Medical Center

Active, not recruiting

Clinical Utility of VI-RADS in Diagnosis of MIBC

Muscle-Invasive Bladder Carcinoma | Radical Cystectomy | Multiparametric MRI | Vesical Imaging Report and Data System

Korea, Republic of
Samsung Medical Center

Enrolling by invitation

Physical Activity in Chronic Obstructive Pulmonary Disease(COPD) Acute Exacerbation Patients

COPD Exacerbation

Korea, Republic of
Samsung Medical Center

Completed

A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor

Pediatric Solid Tumor

Korea, Republic of
Kangbuk Samsung Hospital

Withdrawn

Combined Dexmedetomidine and Glycopyrrolate Therapy

Bladder Irritable
Samsung Medical Center

Completed

Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Head and Neck Cancer

Korea, Republic of
Samsung Medical Center

Completed

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Non-small Cell Lung Cancer

Korea, Republic of
Samsung Medical Center

Completed

Respiratory Protection Effect of Ear-loop-type KF94 Mask

Infection

Korea, Republic of
Samsung Medical Center

Completed

A Study on Brain Activity During Transcranial Direct Current Stimulation in Stroke Patients

Stroke

Korea, Republic of
Samsung Medical Center

Unknown

Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients

Early Gastric Cancer | Gastric Adenoma

Korea, Republic of
Samsung Medical Center

Unknown

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Esophageal Squamous Cell Carcinoma

Korea, Republic of
Samsung Medical Center

Unknown

Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm

Lung Adenocarcinoma, Stage I

Korea, Republic of

3

Subscribe